Top US and Italian Researchers Unite for Cutting-Edge Conference on Medicine, Science, and Technology Hosted by SHRO
Originally published in Newswise The Sbarro Health Research Organization (SHRO), led …
Post & News
Italia-Usa, AmCham and Consul with successful companies
Originally published in Il Mattino AmCham meets successful companies with …
Italia-Usa, AmCham and Consul with successful companies Read More »
SHRO’s Giordano to Speak at Virtual Workshop on Artificial Intelligence in Medicine
Artificial Intelligence and NGS Integrated into the Next Generation Tissue …
SHRO’s Giordano to Speak at Virtual Workshop on Artificial Intelligence in Medicine Read More »
Cancer: In Italy every year over 8000 patients candidates for liquid biopsy
Rome, 21 February 2023 – Almost 8,000 lung cancer patients …
Cancer: In Italy every year over 8000 patients candidates for liquid biopsy Read More »
Malfunctioning Mitochondria at the Heart of Many Cardiovascular Diseases
Newswise Many cardiovascular diseases, such as atherosclerosis, or ‘hardening of …
Malfunctioning Mitochondria at the Heart of Many Cardiovascular Diseases Read More »
Are the Benefits of New Cancer Drugs Worth the Cost?
Newswise — An international research group including scientists from Italy, …
Are the Benefits of New Cancer Drugs Worth the Cost? Read More »
Links Between Neurological Involvement and Respiratory Damage in SARS-CoV-2 Infection
Newswise — Researchers working with Sbarro Health Research Organization (SHRO) …
Links Between Neurological Involvement and Respiratory Damage in SARS-CoV-2 Infection Read More »
Dr. Giordano meets Speaker Nancy Pelosi, De Laurentiis & Petrone at the 47th anniversary of NIAF
Washington D.C. Professor Antonio Giordano founder of Sbarro Health Research …
Cellular Cilium an Early Sign of Mesothelioma Differentiation
As Published on Newswise — A new study investigated the …
Cellular Cilium an Early Sign of Mesothelioma Differentiation Read More »
Adverse Events Linked to PD-1 Blockade in Some Lung Cancer Patients
Original Newswise post Newswise — Treatments with PD-1/PD-L1 immuno-checkpoint inhibitors …
Adverse Events Linked to PD-1 Blockade in Some Lung Cancer Patients Read More »